2m 2m 2m 2m 2m 2m 2m
Prestige Consmer (PBH)
NYSE
$46.97+$0.02 (+0.03%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.2BMarket Cap
- -25.77%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Prestige Consmer (PBH)
$46.97+$0.02 (+0.03%)
PBH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $46.95 | ||
Change | -$0.39 (-0.82%) | ||
Open | $47.68 | ||
High | $47.75 | ||
Low | $46.48 | ||
Previous Close | $47.34 | ||
Volume | 495,641 | ||
30-Day Average Volume | 457,537 | ||
1-Week Change | -10.16% | ||
1-Month Change | -12.41% | ||
1-Year Change | -25.77% | ||
3-Year Change | -18.33% | ||
5-Year Change | -12.24% | ||
Fundamentals | |||
Shares Outstanding | 47.4M | ||
Total Assets | $4.6B | ||
Market Cap | $2.2B | ||
Enterprise Value | $4.2B | ||
Period: QTR TTM FY | |||
Revenue | $260.3M | ||
Net Income | $29.2M | ||
Free Cash Flow | $67.1M | ||
EBIT | $52.5M | ||
EBITDA | $61.2M | ||
Net Working Capital | $343.0M | ||
EPS | $0.61 | ||
Enterprise Value/EBITDA | 68 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 1 | ||
P/E | 77 | ||
PEG | -2 | ||
Price/Free Cash Flow | 33 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/27/2013 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue